TSXV:RHT.H - Post by User
Comment by
lscfaon Apr 21, 2021 1:49pm
110 Views
Post# 33038094
RE:RE:RE:RE:RE:RE:RE:RE:RHT ANNOUNCE 2 NEW CONTRACTS WITH US NEPHROLOGY CLINICS
RE:RE:RE:RE:RE:RE:RE:RE:RHT ANNOUNCE 2 NEW CONTRACTS WITH US NEPHROLOGY CLINICS
$mil cdn. | 2022 est. |
Starting patients | 41,667 |
Ending patients | 65,000 |
Ave patients | 53,333 |
Revenue @ $50/month | 32.0 |
Gross margin | 75% |
Gross profit | 24.0 |
Cash Overhead | 9.6 |
Op inc (ebitda) | 14.4 |
ebitda margin | 45% |
Diluted shs | 180 |
ebitda/sh | $0.080 |
Multiple | 12 |
Sh value | $0.960 |
jtmoney wrote: So then we're trading at roughly 9x this year's revenue and 3x next year's revenue. Assuming they deliver on the numbers.